Sunrest Lifescience IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 09, 2023Let’s have a detailed review of the company and analytics of the Sunrest Lifescience IPO release date, IPO offer price, subscription, Sunrest Lifescience Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
| Face Value | Rs 10 |
| Price Band | Rs 84 |
| Listing At | NSE, SME |
| Min. Order Quantity | 1600 Shares |
| Listing Date | November 20, 2023 |
| Offer for Sale | Rs Lakh |
| Fresh Issue | Rs 1085 Lakh |
| IPO Size | Rs 1085 Lakh |
| Tick Size | 1 |
Sunrest Lifescience IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.
| Live Performance – Sunrest Lifescience Share Price |
Sunrest Lifescience IPO – Summary
Their Company was originally incorporated as “Sunrest Lifescience Private Limited” under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated October 30, 2017, issued by the Registrar of Companies, Ahmedabad.
Subsequently, their Company was converted into a Public Limited Company pursuant to a shareholders resolution passed at the Extra-ordinary General Meeting held on March 09, 2023, and the name of their Company was changed to “Sunrest Lifescience Limited”.
The Promoter of this company is Mr Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakka. The lead manager of the issue is Mark Corporate Advisors Private Limited, and the Registrar of this issue is Skyline Financial Services Private Limited.
Sunrest Lifescience IPO Date
The opening and closing dates of Sunrest Lifescience IPO are November 7, 2023 and November 9, 2023 respectively.
Sunrest Lifescience IPO Subscription
| Day / Date | NII | RII | Total Subscription |
| 1st Day – 7th Nov | 0.62x | 5.86x | 3.24x |
| 2nd Day – 8th Nov | 2.67x | 19.88x | 11.28x |
| 3rd Day – 9th Nov | 29.17x | 65.74x | 48.54x |
| Shares Offered or Net Issue | 612,800 | 612,800 | 1,291,200 |
The shares subscribed by the public will be updated here.
Sunrest Lifescience IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.
Sunrest Lifescience Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
| Basis of Allotment Finalization | November 15, 2023 |
| Refunds Initiation | November 16, 2023 |
| Credit of Shares to Demat Account | November 17, 2023 |
| Share Listing Date | November 20, 2023 |
Sunrest Lifescience IPO Price Band
The face value of each share is Rs.10, but the price band of the IPO is Rs.84
Sunrest Lifescience IPO Equity Size
This Initial Public Issue of 1,291,200 Equity Shares of Rs.10 each for cash at a price of Rs.84 per equity share aggregating to Rs.1085 Lakh.
Sunrest Lifescience IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of 1,291,200 Equity Shares of Rs.10/ each.
Issue Size: 1,291,200 Equity Shares of Rs.10 each, aggregating to Rs.1085 Lakh
Open Free Demat Account Now!
Sunrest Lifescience IPO – Live Performance
The listing date of this IPO is November 20, 2023. You can check the live performance of the IPO here, only after it is listed on exchanges.
| Live IPO Performance – Sunrest Lifescience Share Price |
Sunrest Lifescience IPO Grey Market Premium
The Sunrest Lifescience Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is Rs X.
Sunrest Lifescience IPO – Company Overview
They deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Their product portfolio comprises of wide range of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.
Their company have 18 Registered Trademarks for 32 products. The products of the Company are sold to Stockists and Super Stockists & in turn it is available at Chemist shops, Dispensaries, Hospitals etc.
Their business operations are supported by one of their Group Companies and various third-party manufacturers. They typically work on a third-party manufacturing basis or at times purchase order basis with manufacturers of pharma products, depending upon the customer’s requirement.
Sunrest Lifescience IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
| Amount (in INR & Lakh) | ||||
| 30-Jun-23 | 31-Mar-23 | Mar-22 | 31-Mar-21 | |
| Total Assets | 1706.28 | 1671.37 | 1301.97 | 948.15 |
| *Total Revenue | 563.58 | 2467.05 | 2690.99 | 1694.91 |
| Total Expense | 466.17 | 2192.66 | 2585.96 | 1672.55 |
| Profit After Tax | 75.08 | 204.31 | 77.71 | 16.55 |
Earnings per Equity Share (in Lakh)
| 30-Jun-23 | 31-Mar-23 | Mar-22 | 31-Mar-21 | |
| Basic & Diluted | 2.50 | 6.81 | 2.59 | 0.55 |
Further, their PAT for the period ended on March 31, 2023, March 31, 2022, and March 31, 2021, were Rs. 204.31 Lakh, Rs. 77.71 Lakh and Rs. 16.55 Lakh respectively.
Sunrest Lifescience IPO – Promoters
The Promoter of this company is:
- Mr. Nikhilkumar Y Thakkar,
- Mr. Amitbhai Shambhulal Thakkar,
- Mr. Bhagyesh Kiritbhai Parekh
- Mr. Bharatkumar V Thakkar
List of Related Parties (Key Managerial Personnel)
- Juhi Sawajani, Chairperson and Independent Director
- Nikhil Kumar Y Thakkar, Managing Director
- Amitbhai Shambhulal Thakkar, Whole Time Director
- Bharatkumar V Thakkar, Director
Sunrest Lifescience IPO – Promoters Holding
- Pre-Issue Share Holding – 100%
- Post-Issue Share Holding – 69.91%
Sunrest Lifescience IPO Offer Details or Issue Details
| Particulars | No. Of Equity Shares |
| Equity Shares Offered | Up to 12,91,200 Equity Shares aggregating up to Rs.1084.608 Lakh |
| of which: | |
| Issue Reserved for the Market Makers | Up to 65,600 Equity Shares aggregating up to Rs 55.104 Lakh |
| Net Issue to the Public | Up to 12,25,600 Equity Shares aggregating up to Rs.1029.504 Lakh |
| Of which: | |
| Retail Investors Portion | Not less than 6,12,800 Equity Shares |
| Other than Retail Individual Investors | Not more than 6,12,800 Equity Shares |
| Equity Shares outstanding prior to the Issue | 30,00,000 Equity Shares |
| Equity Shares outstanding after the Issue | 42,91,200 Equity Shares |
Sunrest Lifescience IPO Issue Object
Their Company proposes to utilize the Net Proceeds towards funding the following objects:
- Meeting Working Capital Requirements
- General Corporate Purpose
- Meeting Public Issue Expenses
Sunrest Lifescience IPO – Business Strategy
- Increasing their local presence
- Strengthen their marketing network
Sunrest Lifescience IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Experienced Promoters and Management Team
- Wide range of Products
- Efficient marketing team
The relevant quantitative factors are:
| Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-23 | 6.81 | 65.59 | 10.38 |
| 31-Mar-22 | 2.59 | 72.49 | – |
| Mar-21 | 0.55 | 56.12 | – |
Sunrest Lifescience IPO: Competitive Peers
| Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | Total Income (Rs. in Lakhs) | |
| Sunrest Lifescience Limited | 10 | 12.33 | 6.81 | 5.28 | 2467.05 |
| Listed Peers | |||||
| Trident Lifeline Limited | 10 | 34.91 | 5.23 | 13.18 | 3,169.22 |
| Vaishali Pharma Limited | 10 | 21.54 | 6.26 | 16.29 | 7,582.08 |
| Chandra Bhagat Pharma Limite | 10 | 69.55 | 1.54 | 4.23 | 9,407.56 |
Sunrest Lifescience IPO Lead Managers
| Lead Managers |
| Mark Corporate Advisors Private Limited CIN – U67190MH2008PTC181996 404/1, The Summit Business Bay, Sant Janabai Road (Service Lane), Off W. E. Highway, Vile Parle (East), Mumbai-400 057. Maharashtra, India Tel. No.: +91 22 2612 3208 Email ID: smeipo@markcorporateadvisors.com Investor Grievance Email ID: investorgrievance@markcorporateadvisors.com Contact Person: Mr. Niraj Kothari Website: www.markcorporateadvisors.com; SEBI Regn. No.: INM000012128 |
Sunrest Lifescience IPO Registrar to offer
| Registrar to the Offer |
| Skyline Financial Services Private Limited CIN – U74899DL1995PTC071324 D-153/ A, First Floor, Okhla Industrial Area, Phase – I, New Delhi – 110020 Telephone – +91 1126812682 E-mail id: Virenr@Skylinerta.Com Investor Grievance Email: grievances@skylinerta.com Contact person: Mr. Subhash Dhingreja Website: http://www.skylinerta.com/; SEBI Regn. No.: INR000003241 |
Sunrest Lifescience IPO – Other Details
- Statutory Auditor – M/s Madhusudan C Mashruwala & Co
- Legal Counsel to the Company – Whitespan Law Offices LLP
- Bankers to the Company – Axis Bank Limited
Sunrest Lifescience IPO Review by Stock Brokers
| Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
| Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
| Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
| Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
| ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
| IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
| Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
| Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
| 5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
| Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
| Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to Sunrest Lifescience IPO
Sunrest Lifescience Limited IPO News
News 1 – IPO DRHP Download
News 2 – IPO RHP Prospectus Download
Sunrest Lifescience IPO Review FAQs
Check out various FAQs related to Sunrest Lifescience IPO:
What is the Issue Size of Sunrest Lifescience IPO?
The Company is making an initial public offer of 1,291,200 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.
What is the Price band of Sunrest Lifescience IPO?
The price band for this particular IPO ranges between Rs 84. As far as the face value of the share is concerned, it is Rs. 10 per share.
What is the Sunrest Lifescience IPO Open Date?
The opening and closing dates for this IPO have been updated. The IPO is set to open on November 7, 2023, while the closing date is set at November 9, 2023.
What is the Sunrest Lifescience IPO Allotment Date?
They also have the news regarding the respective allotment dates of this IPO. The basis of Allotment finalization is on November 15, 2023, refund initiation is on November 16, 2023, credit of shares is on November 17, 2023, and share listing date is on November 20, 2023.
What is the Sunrest Lifescience IPO Listing Date?
Shares of this company shall be listed in the exchanges on November 20, 2023. The date, when the listing would be done, is stagnant on November 20, 2023.
Who is the Registrar of Sunrest Lifescience IPO?
One of the reputed registrars is managing the issue of this IPO, i.e. NA. Their website will help you regarding the further information you are on the lookout for.
Who is the Promoter of Sunrest Lifescience IPO?
Here are the promoters of this IPO – Mr Nikhilkumar Y Thakkar, Mr Amitbhai Shambhulal Thakkar, Mr Bhagyesh Kiritbhai Parekh and Mr Bharatkumar V Thakka. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
What is the GMP of Sunrest Lifescience IPO?
They have obtained the GMP of this IPO and it is Rs NA. Further insights into the Kostak rate and subject to sauda or SS are as well included in this report.
Is Sunrest Lifescience IPO Good for Investment?
They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
What is the PAT of Sunrest Lifescience Company?
They have the information on company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2023 in Lakh is 204.31, 2022 is 77.71, and 2021 is 16.55. PAT from Jun 2023 is 75.08.
Calculate your return on investment!
Asset Class
ROI (Rs.)
Profit (Rs.)
Profit (%)
IPO
Equity
Savings
Real Estate
Gold
Bonds
Fixed Deposit
Mutual Fund
Featured Topics